iPSC-derived Microglia in Neurodegeneraton

Induced pluripotent stem cell-derived microglia have recently been developed and provide unlimited access to patient-derived material. These cells can be used to model and investigate mechanism that underlie neurodegenerative diseases. Here is the latest research.

March 5, 2020
Preprint
Open Access

Acoustofluidic Assembly of 3D Neurospheroids to Model Alzheimer's Disease

BioRxiv : the Preprint Server for Biology
Hongwei CaiFeng Guo
May 28, 2020
Open Access

ASC-Exosomes Ameliorate the Disease Progression in SOD1(G93A) Murine Model Underlining Their Potential Therapeutic Use in Human ALS

International Journal of Molecular Sciences
Roberta BonafedeRaffaella Mariotti
July 8, 2020
Review
Open Access

Protective Mechanisms Against DNA Replication Stress in the Nervous System

Genes
Clara Forrer Charlier, Rodrigo A P Martins
February 29, 2020
Review

Regeneration of the central nervous system-principles from brain regeneration in adult zebrafish

World Journal of Stem Cells
Alessandro Zambusi, Jovica Ninkovic
June 11, 2020
Review
Open Access

The Role of Hematopoietic Cell Transplant in the Glycoprotein Diseases

Cells
Brianna M NaumchikTroy C Lund
July 10, 2020
Review

Understanding cause and effect in Alzheimer's pathophysiology: implications for clinical trials

Neuropathology and Applied Neurobiology
Delphine Boche, James A R Nicoll
June 17, 2020

Spinal Cord Injury Leads to Hippocampal Glial Alterations and Neural Stem Cell Inactivation

Cellular and Molecular Neurobiology
Ignacio JureFlorencia Labombarda
April 27, 2020

Microglia alterations in neurodegenerative diseases and their modeling with human induced pluripotent stem cell and other platforms

Progress in Neurobiology
Angélica María Sabogal-GuáquetaAmalia M Dolga
May 30, 2020

Therapeutic Effects of Melatonin-Treated Bone Marrow Mesenchymal Stem Cells (BMSC) in a Rat Model of Alzheimer's Disease

Journal of Chemical Neuroanatomy
Mahdi RamezaniZoleikha Golipoor
April 23, 2020
Comment / Editorial
Open Access

Editorial: Glial and Neural Stem Cells as New Therapeutic Targets for Neurodegenerative Disorders

Frontiers in Cellular Neuroscience
Sara XapelliSandra H Vaz
June 27, 2020
Review
Open Access

MAP/ERK Signaling in Developing Cognitive and Emotional Function and Its Effect on Pathological and Neurodegenerative Processes

International Journal of Molecular Sciences
Héctor Albert-GascóFrancisco E Olucha-Bordonau
June 26, 2020
Review
Open Access

The Role of P2X7 Receptor in Alzheimer's Disease

Frontiers in Molecular Neuroscience
Linda FrancistiováMiguel Díaz-Hernández
July 7, 2020
Open Access

Reduced Fractalkine Levels Lead to Striatal Synaptic Plasticity Deficits in Huntington's Disease

Frontiers in Cellular Neuroscience
Anya KimManuel J Rodríguez
April 8, 2020
Review
Open Access

Why do anti-inflammatory signals of bone marrow-derived stromal cells improve neurodegenerative conditions where anti-inflammatory drugs fail?

Journal of Neural Transmission
J P J M de MunterE Ch Wolters
March 21, 2020
Open Access

Neurodegeneration-Associated Proteins in Human Olfactory Neurons Collected by Nasal Brushing

Frontiers in Neuroscience
Lorenzo BrozzettiGianluigi Zanusso
July 7, 2020
Review

ALS, a cellular whodunit on motor neuron degeneration

Molecular and Cellular Neurosciences
Peter Karagiannis, Haruhisa Inoue
June 13, 2020
Review
Open Access

In vitro Models of Neurodegenerative Diseases

Frontiers in Cell and Developmental Biology
Anna SlanziGabriela Constantin
March 9, 2020
Preprint
Open Access

Inhibition of IL34 unveils tissue-selectivity and is sufficient to reduce microglial proliferation in chronic neurodegeneration

BioRxiv : the Preprint Server for Biology
Juliane ObstDiego Gomez-Nicola

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/ipsc-derived-microglia-in-neurodegeneraton/6c01504b-647e-4cc1-8fe0-c6f0c44622c4